Fact CheckerSign in

NCT03542513Completed

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

Detection of Biomarkers in First-void Urine Samples for Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

Source: ClinicalTrials.gov · Last updated 13 Jun 2025

Brief summary (registry, in English)

The aim of this study is to analyse biomarkers in first-void urine for improved follow-up of women treated for high grade cervical intraepithelial neoplasia (CIN).

Status (registry)
Completed
Study type
Observational
Enrollment
65 (actual)
First submitted
18 May 2018
Start date
30 Oct 2017
Primary completion date
12 Dec 2022
Lead sponsor
Universiteit Antwerpen
NCT number
NCT03542513

What you commit to

  • Study type: Observational
  • Participants enrolled: 65
  • From 30 Oct 2017 to the primary completion date, 12 Dec 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Female (18 years and older)
  • Scheduled for LLETZ treatment of diagnosed, histologically confirmed high grade CIN lesions
  • Giving informed consent to the research team (CEV) to contact his/her GP and/or gynaecologist to access details of the participants HPV vaccination (schedule) and results of cervical smears/cytology, HPV tests, colposcopy, and biopsy.
  • Not participating in another clinical study where a drug or biological is administered.
  • Able to understand the information brochure/what the study is about.

Age in the registry: 18 years to 64 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Antwerp - Centre for the Evaluation of Vaccination
Coordinator of this site? Confirm its status
WilrijkBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.